Menlo Ventures Management
SNTI icon

Menlo Ventures Management’s Senti Biosciences Holdings SNTI Stock Holding History

Menlo Ventures Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.2K Hold
35,737
– – ﹤0.01% 5
2026
Q2 		$39.3K Hold
35,737
– – 0.01% 3
2026
Q1 		$29K Buy
+35,737
New +$34.6K 0.01% 3

Other funds holding SNTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Menlo Ventures Management's SNTI Position: Q3 2026 in Review

Menlo Ventures Management held its Senti Biosciences Holdings (SNTI) position steady in Q3 2026 at 35,737 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5.

Menlo Ventures Management first reported a position in SNTI in Q1 2026 and has held it in 3 quarters since. The position peaked at $39.3K in Q2 2026. 13 funds tracked by Wall St. Rank hold SNTI as of Q3 2026.

  • Menlo Ventures Management held 35,737 shares of Senti Biosciences Holdings worth $11.2K as of Q3 2026.
  • Menlo Ventures Management left its Senti Biosciences Holdings share count unchanged in Q3 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of Menlo Ventures Management's portfolio in Q3 2026, its #5 holding.
  • Menlo Ventures Management first reported a position in Senti Biosciences Holdings in Q1 2026 and has held it in 3 quarters since.
  • Menlo Ventures Management's Senti Biosciences Holdings position peaked at $39.3K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2026.

Based on Menlo Ventures Management's 13F filing for Q3 2026, filed 6 Nov 2026.